Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Mouse Polyclonal (IgG) to Human NTF3 / Neurotrophin 3
Human, Mouse, Rat
Western blot, ELISA
Rabbit Polyclonal to Human NTF3 / Neurotrophin 3
Human, Mouse, Rat, Bovine, Chicken
IHC, Western blot, ELISA
Human NTF3 / Neurotrophin 3
Human, Mouse, Rat, Bovine, Chicken (tested or 100% immunogen sequence identity)
Specificity and Use
A synthetic peptide (YAEHKSHRGEY) as part of human (aa: 139-149), mouse and rat NT3 protein conjugated to BSA. Percent identity by BLAST analysis: Human, Mouse, Rat, Duck, Porcine, Turkey, Bovine, Cat, Chicken (100%).
A cross-reactivity of less than 0.1% to mouse NGF, recombinant human BDNF and NT4/5 has been shown by dot blot. Species cross-reactivity: This antiserum is known to react with rat, chicken and human NT3.
Suitable for use in ELISA, Western Blot and Immunohistochemistry.
Lyophilized powder. Reconstitute in 50 ul of sterile water.
NTF3 / Neurotrophin 3 is a member of the neurotrophin family, that controls survival and differentiation of mammalian neurons. This protein is closely related to both nerve growth factor and brain-derived neurotrophic factor. It may be involved in the maintenance of the adult nervous system, and may affect development of neurons in the embryo when it is expressed in human placenta. NTF3-deficient mice generated by gene targeting display severe movement defects of the limbs.